Insights on mechanisms by which HIV infection inhibits the expression of molecules involved in TLR2-mediated pathways will facilitate the development of modern immunomodulatory strategies of tuberculosis in HIV-positive individuals to enhance innate immunity to M. tuberculosis and prevent latent tuberculosis infection progression to tuberculosis in the highly susceptible HIV-infected population [14]. The gene discussed is TLR2; the disease is HIV infectious disease.